Education
About Us
Working with TipRanks
Follow Us
ADAR1 Capital Management, LLC Insider Profile
4 Followers
ADAR1 Capital Management, LLC, Ten Percent Owner at Palvella Therapeutics, holds 5.39M shares in Keros Therapeutics (Ticker: KROS), holds 144.64K shares in Palvella Therapeutics (Ticker: PVLA). Most recently, ADAR1 Capital Management, LLC Bought ― shares of Keros Therapeutics on Apr 11, 2025 for an estimated value of 9.46M.
ADAR1 Capital Management, LLC has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that ADAR1 Capital Management, LLC holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by ADAR1 Capital Management, LLC
ADAR1 Capital Management, LLC's Trading History
Palvella Therapeutics
Aug 12, 2024
Ten Percent Owner
Informative Buy
92.31K
$2.87M
Keros Therapeutics
Apr 11, 2025
Ten Percent Owner
Informative Buy
9.46M
$65.99M
List of latest transactions for each holding click on a transaction to see ADAR1 Capital Management, LLC's performance on stock
You May Also Like
ADAR1 Capital Management, LLC insider profile FAQ
What is the percentage of profitable transactions made by ADAR1 Capital Management, LLC?
The percentage of profitable transactions made by ADAR1 Capital Management, LLC is ―.
What is the average return per transaction made by ADAR1 Capital Management, LLC?
The average return per transaction made by ADAR1 Capital Management, LLC is ―.
What stocks does ADAR1 Capital Management, LLC hold?
ADAR1 Capital Management, LLC holds: PVLA, KROS stocks.
What was ADAR1 Capital Management, LLC’s latest transaction?
ADAR1 Capital Management, LLC latest transaction was an Informative Buy of $9.46M.
What was ADAR1 Capital Management, LLC's most profitable transaction?
ADAR1 Capital Management, LLC’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is ADAR1 Capital Management, LLC's role in Palvella Therapeutics?
ADAR1 Capital Management, LLC's role in Palvella Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.